Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/04
End: 12/31/06
Due: 12/31/07
Phase: N/A
Priority: Normal
Start: 02/28/14
End: 03/31/16
Due: 03/31/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels | NCT00083928 | Ångstrom Pharmaceuticals | user2@example.com | None | 2004-05-31 | 2006-12-31 | 2007-12-31 | - | - | 2025-07-14 |
| Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL) | NCT02046928 | Ångstrom Pharmaceuticals | user2@example.com | None | 2014-02-28 | 2016-03-31 | 2017-03-31 | - | - | 2025-07-14 |